Navigation Links
Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
Date:9/5/2007

KANNAPOLIS, N.C., Sept. 5 /PRNewswire/ -- A study in the August 2007 issue of Pediatric Diabetes supports the use of the GlycoMark 1,5-anhydroglucitol (1,5-AG) blood test to evaluate therapy in children with diabetes, especially to target postprandial hyperglycemia (elevated after-meal glucose levels). Controlling after-meal glucose levels is important in achieving optimal glycemic control and reducing the burden of cardiovascular complications, the leading cause of death in patients. The data in this study were similar to previous studies in adults.

The study was completed by Rubina Heptulla, MD, from the Department of Pediatrics, Division of Endocrinology and Metabolism at the Baylor College of Medicine and Texas Children's Hospital in Houston, Texas. "These data further demonstrate that the 1,5-AG test is an effective measure of postprandial glucose concentrations and is particularly important in evaluating therapies which have shown efficacy in controlling postprandial hyperglycemia such as exenatide, pramlintide, and sitagliptin," said Dr. Heptulla. "We were also able to demonstrate that the normal range of 1,5-AG in children was similar to normal adults reported in previous studies."

The results of this study are consistent with previous studies reported in adults. In a recent study published in the American Diabetes Association Diabetes Care journal (Dungan et al. Diabetes Care 2006; 29 (6): 1214-1219), it was shown that the GlycoMark 1,5-AG test reflected after-meal glucose levels more robustly than the A1C test. The study also showed that GlycoMark was able to reveal dramatically different after-meal glucose levels in patients with similar A1C levels.

Moreover, studies recently presented at the 67th Annual 2007 Scientific Sessions of the American Diabetes Association and other meetings show that GlycoMark is particularly valuable in detecting underlying treatment effects of agents such as exenatide (Byetta) and pramlintide (Symlin)
'/>"/>

SOURCE GlycoMark
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
4. RT-PCR Primers for the Study of Apoptosis
5. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
6. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
7. New Fusion Trans-Activator Plasmids for Studying Signal Transduction Pathways
8. Medical College receives $377K to study brain disease
9. Kauffman study shows consistent entrepreneurial growth
10. Study affirms information technology-productivity link
11. Deltanoid Pharmaceuticals begins phase II osteoporosis study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... (PRWEB) March 30, 2015 With recent ... provided you the government, major companies are getting into ... governments setting future mandates for renewable energy production, many ... option. , Solara Power is a new solar distribution ... programs available that allow qualifying homeowners to enjoy the ...
(Date:3/30/2015)... & Struggles (Nasdaq: HSII ), the premier provider of ... culture shaping worldwide, today  announced that John Mitchell ... and Life Sciences practice. As Global Practice Managing ... team of more than 80 partners, principals and associates in ... Asia serving clients in the biopharmaceutical, medical technology ...
(Date:3/30/2015)... March 30, 2015 US-Australian drug discovery company, ... subsidiary, CanTx, Inc., and Yale University, on March 27 ... data was presented as an oral presentation by Professor ... School to the 62 nd Annual Scientific Meeting ... San Francisco, CA. In both ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
Breaking Biology Technology:Solara Power Announces Residential Solar Power with No Up-Front Fees 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... , , , NORCROSS, Ga., June 26 ... instrument-reagent systems to the blood transfusion industry, announced that yesterday ... based on an early January 2009 inspection, issued a notice ... to its Reagent Red Blood Cells and Anti-E (Monoclonal) Blood ...
... 26 Syngenta Biotechnology, Inc. announced today that it ... focusing on identifying plant genes related to soybean nematode ... rights to candidate genes discovered by Evogene for use ... soil parasite which attacks the roots of developing plants, ...
... ... synthesis lab and synthetic organic chemist - heating and cooling without an additional cryostat. ... chemistry development tool that requires no training, EasyMax™, and the chance to WIN A SKI ... ...
Cached Biology Technology:Immucor Responds To FDA Notice 2Syngenta and Evogene to Collaborate on Soybean Nematode Resistance 2Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax™: the First Automated Chemistry Development Tool That Requires No Training 2
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/31/2015)... YORK , March 31, 2015   Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... searchable database known as "Threatened ... was developed by a team ... of Florida, the U.S. Fish ... Geological Survey, and the National ...
... create a sustainable food system; studying urban heat ... mountain landscapes are all topics of new grants ... Science Foundation,s (NSF) Science, Engineering and Education for ... NSF,s SEES-Research Coordination Networks (RCN) program. Grants ...
... Ga. Obesity is a major contributor to heart disease ... a cardiologist researching the impact of obesity and weight loss ... demographic group, the country,s problem is only going to get ... of the Medical College of Georgia Section of Cardiology at ...
Cached Biology News:Maintaining Earth's sustainability: Scientists, engineers, educators take coordinated approach 2Maintaining Earth's sustainability: Scientists, engineers, educators take coordinated approach 3Obesity is major contributor to heart disease, impediment to diagnosis and treatment 2Obesity is major contributor to heart disease, impediment to diagnosis and treatment 3
...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
... Amplification Grade digests single- ... oligodeoxyribonucleotides. The specific activity ... I Amplification Grade is ... for absence of RNase ...
Biology Products: